- Medtech Insight
ADA 2021: Encouraging Trial Data On CGMs, Insulin Pens, Digital Solutions, And More
The American Diabetes Association held its 81st Scientific Sessions from 25-29 June, where a range of presentations covering clinical trials of continuous glucose monitors, insulin-delivery systems and remote monitoring technologies were given.
Results of a “real-world” study showed Medtronic’s InPen “smart” insulin-delivery device helped diabetic users improve their glycemic control in conjunction with a continuous glucose monitor.
Medtronic presented results of the study at the American Diabetes Association (ADA) online conference.